PRE 14C

PRELIMINARY INFORMATION STATEMENT

Company: Inhibitor Therapeutics, Inc.
Filed: April 12, 2016
Period of Report: April 12, 2016
Accession Number: 0001193125-16-538601

View Document ↗ View on SEC.gov ↗